+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaccine Adjuvants Market by Application, Delivery Route, End User, Adjuvant Type, Formulation, Vaccine Category - Global Forecast to 2030- Product Image
Vaccine Adjuvants Market by Application, Delivery Route, End User, Adjuvant Type, Formulation, Vaccine Category - Global Forecast to 2030- Product Image
Sale

Vaccine Adjuvants Market by Application, Delivery Route, End User, Adjuvant Type, Formulation, Vaccine Category - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5675209
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers seeking to navigate the evolving vaccine adjuvants market need actionable insights into innovation, supply chain complexities, and competitive dynamics shaping global industry growth. The vaccine adjuvants market faces transformative change as new technologies, regulatory frameworks, and regional priorities converge to impact development, commercialization, and procurement strategies.

Market Snapshot: Vaccine Adjuvants Market Size and Growth

The Vaccine Adjuvants Market grew from USD 884.18 million in 2024 to USD 957.88 million in 2025. It is expected to continue growing at a CAGR of 8.02%, reaching USD 1.40 billion by 2030. Expansion is driven by ongoing R&D, global shifts in disease priority, trade policy changes, and demand for advanced vaccine formulations suited to novel pathogen threats as well as therapeutic applications.

Scope & Segmentation of the Vaccine Adjuvants Industry

  • Applications: Animal vaccines, including aquaculture, companion animals, and livestock; prophylactic vaccines to prevent diseases; therapeutic vaccines targeting treatment of existing conditions.
  • Delivery Routes: Intramuscular, intranasal, oral, and subcutaneous pathways are leveraged to optimize immune efficacy and accessibility in diverse settings.
  • End Users: Clinics—both outpatient and specialty; hospitals across private and public sectors; research institutes comprising government organizations and private laboratories.
  • Adjuvant Types: Includes aluminum salts (hydroxide and phosphate), CpG oligodeoxynucleotides, emulsion-based adjuvants (AS03, MF59), liposome-based (cationic, neutral), and saponin-based options (ISCOMs, QS-21).
  • Formulation Approaches: Emulsions, ISCOMs, liposomes, particulates, and saponin complexes support targeted delivery, dose-sparing, and tailored immune responses.
  • Vaccine Categories: Bacterial (conjugate, toxoid), DNA, mRNA, recombinant, and viral vaccines (inactivated, live attenuated, subunit).
  • Geographic Coverage: Americas (with detail across the U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (select major markets), and Asia-Pacific (China, India, Japan, Australia, and others).
  • Leading Companies: GlaxoSmithKline plc, Merck & Co., Inc., Sanofi S.A., CSL Limited, Dynavax Technologies Corporation, Novavax, Inc., Takeda Pharmaceutical Company Limited, Croda International Plc, Evonik Industries AG, and Pfizer Inc.

Key Takeaways for Strategic Decision-Making

  • Novel adjuvant systems, such as CpG oligonucleotides and advanced emulsions, are transitioning from research to commercial use, providing more targeted immune response modulation beyond traditional aluminum salts.
  • Growing adoption of mRNA and DNA vaccines increases the importance of adjuvants that enable intracellular delivery and stabilization, especially where traditional platforms have limitations.
  • The market is increasingly segmented by application, delivery route, and vaccine type, reflecting the need for customized solutions to support human and animal health priorities.
  • Strategic collaborations—spanning dedicated R&D units and co-development partnerships—are vital for addressing complexity in formulation science and regulatory compliance.
  • Regional investment in vaccine self-sufficiency, especially across Asia-Pacific, is accelerating the adoption of both legacy and cutting-edge adjuvant technology, supporting rapid response to evolving epidemiological needs.
  • Contract manufacturing organizations are expanding capabilities to support advanced adjuvant production, providing flexibility and scale for both established manufacturers and emerging biotech firms.

Tariff Impact: Adjustments in US Vaccine Adjuvant Supply Chains

The 2025 United States tariff schedule imposes new duties on raw materials and adjuvant formulations, challenging suppliers dependent on global lipid and excipient sourcing. Manufacturers have responded by increasing domestic aluminum-based production and developing partnerships to secure oligonucleotide and saponin imports. While initial cost pressures emerged, these adjustments have prompted investment in advanced, scalable production lines. The mid-decade outlook points to increased domestic resilience and more robust procurement strategies for health agencies and vaccine developers.

Methodology & Data Sources

This report draws on primary interviews with industry experts and secondary sources such as peer-reviewed journals, patent databases, and company disclosures. Proprietary analytical frameworks and rigorous quality controls support segmentation mapping and trend validation, ensuring high integrity and confidentiality in all findings.

Why This Report Matters

  • Enables strategic planning with granular segmentation and regional analysis to inform R&D and market entry decisions.
  • Offers clear evidence on supply chain resilience, innovation trends, and regulatory factors critical for long-term procurement and commercialization outcomes.

Conclusion

As vaccine technologies diversify and global policy evolves, success in the vaccine adjuvants market will rely on informed, agile strategies. This report delivers a robust foundation for navigating growth, disruption, and opportunity in a rapidly advancing domain.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vaccine Adjuvants Market, by Application
8.1. Introduction
8.2. Animal Vaccines
8.2.1. Aquaculture
8.2.2. Companion Animals
8.2.3. Livestock
8.3. Prophylactic Vaccines
8.4. Therapeutic Vaccines
9. Vaccine Adjuvants Market, by Delivery Route
9.1. Introduction
9.2. Intramuscular
9.3. Intranasal
9.4. Oral
9.5. Subcutaneous
10. Vaccine Adjuvants Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Outpatient Clinics
10.2.2. Specialty Clinics
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Research Institutes
10.4.1. Government Institutes
10.4.2. Private Laboratories
11. Vaccine Adjuvants Market, by Adjuvant Type
11.1. Introduction
11.2. Aluminum Salts
11.2.1. Aluminum Hydroxide
11.2.2. Aluminum Phosphate
11.3. CpG Oligodeoxynucleotides
11.4. Emulsion Based
11.4.1. AS03
11.4.2. MF59
11.5. Liposome Based
11.5.1. Cationic Liposomes
11.5.2. Neutral Liposomes
11.6. Saponin Based
11.6.1. ISCOMs
11.6.2. QS-21
12. Vaccine Adjuvants Market, by Formulation
12.1. Introduction
12.2. Emulsions
12.3. ISCOMs
12.4. Liposomes
12.5. Particulates
12.6. Saponin Complexes
13. Vaccine Adjuvants Market, by Vaccine Category
13.1. Introduction
13.2. Bacterial Vaccines
13.2.1. Conjugate
13.2.2. Toxoid
13.3. DNA Vaccines
13.4. mRNA Vaccines
13.5. Recombinant Vaccines
13.6. Viral Vaccines
13.6.1. Inactivated
13.6.2. Live Attenuated
13.6.3. Subunit
14. Americas Vaccine Adjuvants Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Vaccine Adjuvants Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Vaccine Adjuvants Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GlaxoSmithKline plc
17.3.2. Merck & Co., Inc.
17.3.3. Sanofi S.A.
17.3.4. CSL Limited
17.3.5. Dynavax Technologies Corporation
17.3.6. Novavax, Inc.
17.3.7. Takeda Pharmaceutical Company Limited
17.3.8. Croda International Plc
17.3.9. Evonik Industries AG
17.3.10. Pfizer Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. VACCINE ADJUVANTS MARKET MULTI-CURRENCY
FIGURE 2. VACCINE ADJUVANTS MARKET MULTI-LANGUAGE
FIGURE 3. VACCINE ADJUVANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VACCINE ADJUVANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. VACCINE ADJUVANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. VACCINE ADJUVANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VACCINE ADJUVANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VACCINE ADJUVANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PROPHYLACTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PRIVATE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CPG OLIGODEOXYNUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY AS03, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY MF59, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CATIONIC LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY NEUTRAL LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ISCOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY QS-21, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ISCOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PARTICULATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN COMPLEXES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CONJUGATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY TOXOID, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 103. CANADA VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CANADA VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 105. CANADA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 106. CANADA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. CANADA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 108. CANADA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. CANADA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 110. CANADA VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 111. CANADA VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 112. CANADA VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 113. CANADA VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 114. CANADA VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 115. CANADA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. CANADA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 117. CANADA VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 118. CANADA VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 119. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 126. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 129. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 130. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 131. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 200. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 202. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 203. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 205. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 206. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 207. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 208. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 209. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 210. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 211. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 212. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 213. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 214. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 215. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 216. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 218. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 219. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 221. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 223. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 224. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 225. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 226. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 227. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 228. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 229. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 230. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 231. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 248. ITALY VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. ITALY VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 250. ITALY VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 251. ITALY VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. ITALY VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. ITALY VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 254. ITALY VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 255. ITALY VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 256. ITALY VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 257. ITALY VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 258. ITALY VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 259. ITALY VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 260. ITALY VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 261. ITALY VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 262. ITALY VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 263. ITALY VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 264. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 266. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 267. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 269. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 270. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 271. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 272. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 273. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 274. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 275. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 276. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 278. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 279. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 326. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 328. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY ANIMAL VACCINES, 2018-2030 (USD MILLION)
TABLE 330. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 331. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 333. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 334. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 335. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY ADJUVANT TYPE, 2018-2030 (USD MILLION)
TABLE 336. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY ALUMINUM SALTS, 2018-2030 (USD MILLION)
TABLE 337. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY EMULSION BASED, 2018-2030 (USD MILLION)
TABLE 338. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOME BASED, 2018-2030 (USD MILLION)
TABLE 339. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN BASED, 2018-2030 (USD MILLION)
TABLE 340. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 341. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2030 (USD MILLION)
TABLE 342. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, 2018-2030 (USD MILLION)
TABLE 343. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, 2018-2030 (USD MILLION)
TABLE 344. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vaccine Adjuvants market report include:
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • CSL Limited
  • Dynavax Technologies Corporation
  • Novavax, Inc.
  • Takeda Pharmaceutical Company Limited
  • Croda International Plc
  • Evonik Industries AG
  • Pfizer Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 957.88 Million
Forecasted Market Value ( USD ) by 2030 $ 1400 Million
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type, By Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type, By Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029 - Product Image

Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029

  • Report
  • 389 Pages
  • Global
From
Vaccine Adjuvants Market Report 2025 - Product Image

Vaccine Adjuvants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2024-2032 - Product Image

Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.